SL
WST icon

Savior LLC’s West Pharmaceutical WST Stock Holding History

Savior LLC’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-8
Closed -$3K – 799
2021
Q2 		$3K Hold
8
– – ﹤0.01% 700
2021
Q1 		$2K Hold
8
– – ﹤0.01% 788
2020
Q4 		$2K Hold
8
– – ﹤0.01% 757
2020
Q3 		$2K Hold
8
– – ﹤0.01% 722
2020
Q2 		$2K Hold
8
– – ﹤0.01% 687
2020
Q1 		$1K Hold
8
– – ﹤0.01% 773
2019
Q4 		$1K Buy
+8
New +$1.17K ﹤0.01% 879

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $40.7B AUM 39.97% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Savior LLC's WST Position: Q3 2021 in Review

Savior LLC sold out of West Pharmaceutical (WST) in Q3 2021, closing a stake of 8 shares — an estimated $3K sold.

Savior LLC first reported a position in WST in Q4 2019 and held it in 7 quarters. The position peaked at $3K in Q2 2021. 670 funds tracked by Wall St. Rank hold WST as of Q3 2021.

  • Savior LLC reported no remaining West Pharmaceutical position as of Q3 2021 after selling out during the quarter.
  • Savior LLC sold 8 West Pharmaceutical shares in Q3 2021, an estimated $3K.
  • Savior LLC first reported a position in West Pharmaceutical in Q4 2019 and held it in 7 quarters.
  • Savior LLC's West Pharmaceutical position peaked at $3K in Q2 2021.
  • 670 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2021.

Based on Savior LLC's 13F filing for Q3 2021, filed 5 Oct 2021.